0001114220-17-000028.txt : 20170913 0001114220-17-000028.hdr.sgml : 20170913 20170913205734 ACCESSION NUMBER: 0001114220-17-000028 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170911 FILED AS OF DATE: 20170913 DATE AS OF CHANGE: 20170913 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Enyedy Mark J CENTRAL INDEX KEY: 0001586965 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-30929 FILM NUMBER: 171084392 MAIL ADDRESS: STREET 1: C/O FATE THERAPEUTICS, INC. STREET 2: 3535 GENERAL ATOMICS COURT, SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: KERYX BIOPHARMACEUTICALS INC CENTRAL INDEX KEY: 0001114220 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 134087132 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE MARINA PARK DR. CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 617-466-3500 MAIL ADDRESS: STREET 1: ONE MARINA PARK DR. CITY: BOSTON STATE: MA ZIP: 02210 4 1 wf-form4_150535063941262.xml FORM 4 X0306 4 2017-09-11 0 0001114220 KERYX BIOPHARMACEUTICALS INC KERX 0001586965 Enyedy Mark J C/O KERYX BIOPHARMACEUTICALS, INC. ONE MARINA PARK DRIVE, 12TH FLOOR BOSTON MA 02210 1 0 0 0 Stock Options (right to buy) 7.32 2017-09-11 4 A 0 50000 7.32 A 2018-09-11 2027-09-11 Common Stock 50000.0 50000 D The 50,000 stock options vest as follows: 16,667 on September 11, 2018; 16,667 on September 11, 2019; 16,666 on September 11, 2020. /s/ Brian Adams, Attorney-in-Fact 2017-09-13